Evaluation of therapeutic properties of fermented vegetables extract (OM-X®) in the model of colitis induced by Citrobacter rodentium in mice

Journal of Functional Foods

Volumn 10, Issue , 2014, Pages 117-127

  Takahata, Muneaki ^a   Frémont, Marc ^b   Desreumaux, Pierre ^c,d,e   Rousseaux, Christel ^c   Dubuquoy, Caroline ^c   Shimomiya, Yoshie ^a   Nakamura, Yuki ^a   Miyake, Yasuyoshi ^a  

^a BIOBANK Co Ltd   (Japan)

^b Parc Eurasanté   (France)

^c UNIV LILLE   (France)

^d UNIVERSITÉ DE LILLE   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Citrobacter rodentium; Epithelium; Inflammation; Microbiota; Tight junction

Indexed keywords

BACTERIA (MICROORGANISMS); BASIDIOMYCOTA; CITROBACTER RODENTIUM; CLOSTRIDIUM; MUS;

EID: 84919969163     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.06.003     Document Type: Article

References (48)

1. Aboulnaga H., Pinkenburg O., Schiffels J., El-Refai A., Buckel W., Selmer T. Effect of an oxygen-tolerant butyril-coenzyme A dehydrogenase/ electron-transferring flavoprotein complex from Clostridium difficile on butyrate production in Escherichia coli. Journal of Bacteriology 2013, 195:3704-3713.
2. Abramoff M.D., Magalhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics International 2004, 11(7):36-42.
3. Al-Sheraji S.H., Ismail A., Manap M.Y., Mustafa S., Yusof R.M., Hassan F.A. Prebiotics as functional foods: A review. Journal of Functional Foods 2013, 5:1542-1553.
4. Ameho C.K., Adjei A.A., Harrison E.K., Takeshita K., Morioka T., Arakaki Y., Ito E., Suzuki I., Kulkarni A., Kawajiri A., Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997, 41:487-493.
5. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., de Roos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., Rudensky A.Y. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
6. Ashraf R., Vasiljevic T., Day S.L., Smith S.C., Donkor O.N. Lactic acid bacteria and probiotic organisms induce different cytokine profile and regulatory T cells mechanisms. Journal of Functional Foods 2014, 6:395-409.
7. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., Fukuda S., Saito T., Narushima S., Hase K., Kim S., Fritz J.V., Wilmes P., Ueha S., Matsushima K., Ohno H., Olle B., Sakaguchi S., Taniguchi T., Morita H., Hattori M., Honda K. Treg induction by a rationally selected mixture of Clostridium strains from human microbiota. Nature 2013, 500:232-236.
8. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., Taniguchi T., Takeda K., Hori S., Ivanov I.I., Umesaki Y., Itoh K., Honda K. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
9. Balzan S., de Almeida-Quadros C., de Cleva R., Zilberstein B., Cecconello I. Bacterial translocation: Overview of mechanisms and clinical impact. Journal of Gastroenterology and Hepatology 2007, 22:464-471.
10. Chen C.C., Louie S., Shi H.N., Walker W.A. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatric Research 2005, 58:1185-1191.
11. Duncan S.H., Barcenilla A., Stewart C.S., Pryde S.E., Flint H.J. Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from human large intestine. Applied and Environmental Microbiology 2002, 68:5186-5190.
12. Fanning A.S., Anderson J.M. Zonula occludins-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Annals of the New York Academy of Sciences 2009, 1165:113-120.
13. Fogliano V., Morales F.J. Estimation of dietary intake of melanoidins from coffee and bread. Food & Function 2011, 2:117-123.
14. Furusawa Y., Obata Y., Fukuda S., Nakato G., Takahashi D., Nakanishi Y., Uetake C., Kato K., Kato T., Takahashi M., Fukuda N.N., Murakami S., Miyauchi E., Hino S., Onawa S., Fujimura Y., Lockett T., Clarke J.M., Topping D.L., Tomita M., Hori S., Ohara O., Morita T., Koseki H., Kikuchi J., Honda K., Hase K., Ohno H. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
15. Geiger T.L., Tauro S. Nature and nurture in Foxp3(+) regulatory T cell development, stability, and function. Human Immunology 2012, 73:232-239.
16. Ghosh S., Dai C., Brown K., Rajendiran E., Makarenko S., Baker J., Ma C., Halder S., Montero M., Ionescu V.A., Klegeris A., Vallance B.A., Gibson D.L. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. American Journal of Physiology. Gastrointestinal and Liver Physiology 2011, 301:G39-G49.
17. Goldstein J., Morris W.E., Loidl C.F., Tironi-Farinati C., McClane B.A., Uzal F.A., Miyakawa M.E. Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS ONE 2009, e7065.
18. Guttman J.A., Samji F.N., Li Y., Vogi A.W., Finlya B.B. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infection and Immunity 2006, 74:6075-6084.
19. Hansen A., Alston L., Tulk S.E., Schenck L.P., Grassie M.E., Alhassan B.F., Veermalla A.T., Al-Bashir S., Gendron F.P., Altier C., MacDonald J.A., Beck P.L., Hirota S.A. The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction. PLoS ONE 2013, 8:e81491.
20. Hartmanis M.G. Butyrate kinase from Clostridium acetobutylicum. The Journal of Biological Chemistry 1987, 262:617-621.
21. Hashim B.Y., Rahman R.A., Philip K. Lactic acid bacteria is beneficial for oral aphthous ulcerations. Annals of Dentistry 1999, 1:44-47.
22. Hu X., Ivashkiv L.B. Cross-regulation of signaling and immune responses by IFN-gamma and STAT1. Immunity 2009, 31(4):539-550.
23. Iizuka M., Konno S. Wound healing of intestinal epithelial cells. World Journal of Gastroenterology 2011, 17:2161-2171.
24. Ilan Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World Journal of Gastroenterology 2012, 18:2609-2618.
25. Kapar J.B., Nataro J.P., Mobley H.L. Pathogenic Escherichia coli. Nature Reviews. Microbiology 2004, 2:123-140.
26. Kawakami M., Ohhira I., Araki N., Inokihara K., Iwasaki H., Matsubara T. The influence of lactic acid bacteria (OM-X) on bone structure. The Journal of Applied Nutrition 2003, 53:2-8.
27. Klatt N.R., Funderburg N.T., Brenchley J.M. Microbial translocation, immune activation, and HIV disease. Trends in Microbiology 2013, 21:6-13.
28. Lara-Villoslada F., Debras E., Nieto A., Concha A., Gálvez J., López-Huertas E., Boza J., Obled C., Xaus J. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clinical Nutrition 2006, 25:477-488.
29. Liu X., Yang G., Geng X.R., Cao Y., Li N., Ma L., Chen S., Yang P.C., Liu A. Microbial products induce claudin-2 to compromise gut epithelial barrier function. PLoS ONE 2013, 8:e68547.
30. Louis P., Duncan S.H., McCrae S.I., Millar J., Jackson M.S., Flint H.J. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. Journal of Bacteriology 2004, 186:2099-2106.
31. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiology Letters 2009, 294:1-8.
32. Maaser C., Housley M.P., Iimura M., Smith J.R., Vallance B.A., Finlay B.B., Schreiber J.R., Varki N.M., Kagnoff M.F., Eckmann L. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infection and Immunity 2004, 72:3315-3324.
33. Mundy R., MacDonald T.T., Dougan G., Frankel G., Wiles S. Citrobacter rodentium of mice and man. Cell 2005, 7:1697-1706.
34. Murai M., Turovskaya O., Kim G., Madan R., Karp C.L., Cheroutre H., Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature Immunology 2009, 10:1178-1184.
35. Peshev D., Van den Ende W. Fructans: Prebiotics and immunomodulators. Journal of Functional Foods 2014, 8:348-357.
36. Pryde S.E., Duncan S.H., Hold G.L., Stewart C.S., Flint H.J. The microbiology of butyrate formation in the human colon. FEMS Microbiology Letters 2002, 217:133-139.
37. Rodrigues D.M., Sousa A.J., Johnson-Henry K.C., Sherman P.M., Gareau M.G. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice. The Journal of Infectious Diseases 2012, 206:99-109.
38. Sanders M.E., Guarner F., Guerrant R., Holt P.R., Quigley E.M., Sartor R.B., Sherman P.M., Mayer E.A. An update on the use and investigation of probiotics in health and disease. Gut 2013, 62:787-796.
39. Schauer D.B., Falkow S. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infection and Immunity 1993, 61:2486-2492.
40. Simmons C.P., Clare S., Ghaem-Maghami M., Uren T.K., Rankin J., Huett A., Goldin R., Lewis D.J., MacDonald T.T., Strugnell R.A., Frankel G., Dougan G. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infection and Immunity 2003, 71:5077-5086.
41. Spierings E.L.H., Walshe T., Pescatore F. Safety and tolerability of Dr Ohhira's OM-X capsules in healthy volunteers. Integrative Medicine 2013, 12:38-42.
42. Symonds E.L., Riedel C.U., O'Mahony D., Lapthorne S., O'Mahony L., Shanahan F. Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage. Clinical and Experimental Immunology 2009, 157:148-154.
43. Thelemann C., Eren R.O., Coutaz M., Brasseit J., Bouzourene H., Rosa M., Duval A., Lavanchy C., Mack V., Mueller C., Reith W., Acha-Orbea H. Interferon-gamma induces expression of MHC class II on intestinal epithelial cells and protects mice from colitis. PLoS ONE 2014, 9(1). e86844.
44. Tsukita S., Katsuno T., Yamazaki Y., Umeda K., Tamura A., Tsukita S. Roles of ZO-1 and ZO-2 in establishment of the belt-like adherens and tight junctions with paracellular permselective barrier function. Annals of the New York Academy of Sciences 2009, 1165:44-52.
45. Vital M., Penton R.C., Wang Q., Young B.V., Antonopoulos A.D., Sogin L.M., Morrison G.H., Raffals L., Chang B.E., Huffnagle B.G., Schmidt M.T., Cole R.J., Tiedje M.J. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome 2013, 1:8.
46. Welinder-Olsson C., Kaifser B. Enterohemorrhagic Escherichia coli (EHEC). Scandinavian Journal of Infectious Diseases 2005, 37:405-416.
47. Wiles S., Clare S., Harker J., Huett A., Young D., Dougan G., Frankel G. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cellular Microbiology 2004, 6:963-972.
48. Yousef M., Pichyangkura R., Soodvilai S., Chatsudthipong V., Muanprasat C. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: Therapeutic efficacy and possible mechanisms of action. Pharmacological Research 2012, 66:66-79.